Ke Ning Bio is an innovative ophthalmic pharmaceutical manufacturer dedicated to developing ophthalmic drugs.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 1, 2022 | Seed | ¥100M | 1 | Longqian Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Longqian Capital | Yes | Seed |